ANIMATION

HuLuc 63

Share this animation:

PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein expressed only on the surface of myeloma cells. This initiates antibody-dependent cytotoxic activity which targets myeloma cells while leaving healthy cells intact.

Share It:
Contact XVIVO

Client


PDL BioPharma

XVIVO was an absolute pleasure to work with. Our project with XVIVO was our very first animation project and their team guided us through the process with no difficulty. The people that we worked with were very talented and made the whole process enjoyable. Their attention to the details was superb. We are completely satisfied with the end result and is a product that we can continue to use in the future. We will work with them again.

Manager, New Business Development, Ajinomoto
Share this animation: